Bergsteiger Life Sciences Llp
Founded in 2018 and headquartered in Maharashtra, India.
2018 | Aurangabad, Maharashtra (India) | Active
Bergsteiger Life Sciences Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Bergsteiger Life Sciences Llp
Bergsteiger Life Sciences Llp (BLSL) is 6 Year, 2 Months old Limited Liability Partnership 27 December 2018. Its registered office is in Aurangabad, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2024 (FY 2023-2024). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAN-8565
- Incorporation Date
27 Dec 2018
- Date of Accounts and Solvency Statement
31 Mar 2024
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Chemicals
Who are the key members and board of directors at Bergsteiger Life Sciences Llp?
Designated Partners (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohseena Ali  | Designated Partner | 27-Dec-2018 | Current |
| Chand Ahemad | Designated Partner | 27-Dec-2018 | Current |
| Suraiya Zama | Designated Partner | 27-Dec-2018 | Current |
| Heena Syed | Designated Partner | 27-Dec-2018 | Current |
| Sobiya Khanam | Designated Partner | 27-Dec-2018 | Current |
| Amreen Chisty | Designated Partner | 27-Dec-2018 | Current |
Financial Performance of Bergsteiger Life Sciences Llp.
Enhance accessibility to Bergsteiger Life Sciences Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bergsteiger Life Sciences Llp?
Unlock access to Bergsteiger Life Sciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Zehza Life Sciences Private Limited
Heena Syed is a mutual person
- Medbolt Pharmaceutical Private Limited
Sobiya Khanam is a mutual person
- Tooba Global Pharmaceutical Private Limited
Sobiya Khanam is a mutual person
- Paznic Life Sciences Private Limited
Sobiya Khanam is a mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Bergsteiger Life Sciences Llp?
Unlock and access historical data on people associated with Bergsteiger Life Sciences Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bergsteiger Life Sciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bergsteiger Life Sciences Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.